Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.358B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 5,220,846 | $230M | 16.9% | $18.57 | +102.0% | COM | 80706P103 |
| KRYS | KRYSTAL BIOTECH INC | 677,705 | $167M | 12.3% | $62.38 | +237.4% | COM | 501147102 |
| NRIX | NURIX THERAPEUTICS INC | 8,093,908 | $154M | 11.3% | $17.18 | -16.4% | COM | 67080M103 |
| STOK | STOKE THERAPEUTICS INC | 4,034,070 | $128M | 9.4% | $9.00 | +234.1% | COM | 86150R107 |
| IMNM | IMMUNOME INC | 5,718,385 | $123M | 9.0% | $11.49 | +52.8% | COM | 45257U108 |
| RGNX | REGENXBIO INC | 4,368,804 | $62.91M | 4.6% | $22.74 | -45.2% | COM | 75901B107 |
| ADCT | ADC THERAPEUTICS SA | 15,666,731 | $55.3M | 4.1% | $19.52 | -79.2% | SHS | H0036K147 |
| COGT | COGENT BIOSCIENCES INC | 1,437,918 | $51.07M | 3.8% | $9.95 | +182.5% | COM | 19240Q201 |
| ANNX | ANNEXON INC | 10,050,644 | $50.45M | 3.7% | $9.79 | -61.0% | COM | 03589W102 |
| BEAM | BEAM THERAPEUTICS INC | 1,285,859 | $35.64M | 2.6% | $26.47 | -3.6% | COM | 07373V105 |
| NGNE | NEUROGENE INC | 1,459,599 | $30.07M | 2.2% | $22.00 | +13.1% | COM | 64135M105 |
| RAPT | RAPT THERAPEUTICS INC | 885,927 | $30.01M | 2.2% | $16.44 | +88.9% | COM NEW | 75382E208 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $28.8M | 2.1% | $19.01 | -80.8% | COM | 00091E109 |
| NUVB | NUVATION BIO INC | 3,163,256 | $28.34M | 2.1% | $10.97 | -43.5% | COM CL A | 67080N101 |
| IDYA | IDEAYA BIOSCIENCES INC | 742,017 | $25.65M | 1.9% | $27.49 | +16.0% | COM | 45166A102 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $20.22M | 1.5% | $32.14 | -92.6% | COM | 82024L103 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $13.16M | 1.0% | $18.53 | — | ADS | 82686Q101 |
| ZYME | ZYMEWORKS INC | 491,654 | $12.95M | 1.0% | $7.05 | +209.5% | COM | 98985Y108 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $12.65M | 0.9% | $13.12 | -90.9% | COM | 31189P102 |
| REPL | REPLIMUNE GROUP INC | 1,099,756 | $10.69M | 0.8% | $12.40 | -31.5% | COM | 76029N106 |
| DBVT | DBV TECHNOLOGIES S A | 549,840 | $10.54M | 0.8% | $19.17 | — | SPONSORED ADS | 23306J309 |
| SLDB | SOLID BIOSCIENCES INC | 1,860,542 | $10.49M | 0.8% | $4.65 | +16.5% | COM NEW | 83422E204 |
| CBLL | CERIBELL INC | 435,239 | $9.545M | 0.7% | $27.25 | -43.0% | COM | 15678C102 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 112,664 | $8.211M | 0.6% | $44.21 | +36.6% | COM | G31249108 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $7.99M | 0.6% | $15.04 | -0.7% | COM NEW | 046513206 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 283,308 | $7.695M | 0.6% | $11.60 | +127.1% | COM NEW | 15117B202 |
| LIVN | LIVANOVA PLC | 118,054 | $7.264M | 0.5% | $70.40 | -18.8% | SHS | G5509L101 |
| IVVD | INVIVYD INC | 2,681,159 | $6.622M | 0.5% | $16.17 | -87.1% | COM | 00534A102 |
| XENE | XENON PHARMACEUTICALS INC | 133,882 | $6.001M | 0.4% | $42.00 | 0.0% | COM | 98420N105 |
| — | REPARE THERAPEUTICS INC | 1,586,174 | $4.124M | 0.3% | $30.51 | — | COM | 760273102 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,264,718 | $3.689M | 0.3% | $15.46 | -90.2% | COM | 00166B105 |
| ORIC | ORIC PHARMACEUTICALS INC | 448,110 | $3.666M | 0.3% | $11.51 | 0.0% | COM | 68622P109 |
| PLRX | PLIANT THERAPEUTICS INC | 1,616,228 | $1.972M | 0.1% | $22.50 | -93.3% | COM | 729139105 |
| KLRS | KALARIS THERAPEUTICS INC | 82,955 | $700K | 0.1% | $9.79 | -34.7% | COM | 482929106 |